Intracranial Aneurysm Market Growth, Size & Share Analysis

Intracranial Aneurysm Market Competitive Landscape

Intracranial Aneurysm Market Top Player’s Company Profiles

Medtronic plc - Ireland

Johnson & Johnson - United States

Stryker Corporation - United States

MicroPort Scientific Corporation - China

Terumo Corporation - Japan

Penumbra, Inc. - United States

Abbott Laboratories - United States

MicroVention, Inc. (subsidiary of Terumo Corporation) - United States

Balt Extrusion - France

Merit Medical Systems, Inc. - United States

Phenox GmbH - Germany

Sequent Medical (now part of Terumo Corporation) - United States

W. L. Gore & Associates, Inc. - United States

Shape Memory Medical Inc. - United States

Gynesonics, Inc. - United States

Medikit Co., Ltd. - Japan

Oxford Endovascular Ltd. - United Kingdom

DePuy Synthes (a subsidiary of Johnson & Johnson) - United States

Rapid Medical Ltd. - Israel

Orsan Medical Technologies Ltd. - Israel

Intracranial Aneurysm Market

FAQs

Intracranial Aneurysm Market size was valued at USD 1.20 billion in 2022 and is poised to grow from USD 1.30 billion in 2023 to USD 2.60 billion by 2031, at a CAGR of 9.0% during the forecast period (2024-2031).

The competitive landscape of the global intracranial aneurysm market is characterized by intense rivalry among key players striving to establish their presence and gain a competitive edge. Leading medical device manufacturers, healthcare institutions, and research organizations are actively involved in developing innovative products and advancing treatment options for intracranial aneurysms. These companies continuously invest in research and development to bring novel devices and therapeutic approaches to the market. Additionally, strategic collaborations, partnerships, and mergers are common strategies adopted by players to expand their product portfolios and geographical reach. 'Medtronic plc - Ireland', 'Johnson & Johnson - United States', 'Stryker Corporation - United States', 'MicroPort Scientific Corporation - China', 'Terumo Corporation - Japan', 'Penumbra, Inc. - United States', 'Abbott Laboratories - United States', 'MicroVention, Inc. (subsidiary of Terumo Corporation) - United States', 'Balt Extrusion - France', 'Merit Medical Systems, Inc. - United States', 'Phenox GmbH - Germany', 'Sequent Medical (now part of Terumo Corporation) - United States', 'W. L. Gore & Associates, Inc. - United States', 'Shape Memory Medical Inc. - United States', 'Gynesonics, Inc. - United States', 'Medikit Co., Ltd. - Japan', 'Oxford Endovascular Ltd. - United Kingdom', 'DePuy Synthes (a subsidiary of Johnson & Johnson) - United States', 'Rapid Medical Ltd. - Israel', 'Orsan Medical Technologies Ltd. - Israel'

Advances in medical technology, such as minimally invasive endovascular procedures, improved imaging techniques, and the development of novel devices, can drive market growth. These advancements often lead to better treatment outcomes, reduced patient discomfort, and shorter recovery times.

There has been a growing trend towards minimally invasive procedures for treating intracranial aneurysms. Endovascular techniques, such as coiling and flow diversion, have gained popularity due to their reduced invasiveness and shorter recovery times compared to traditional open surgical approaches. These procedures involve threading catheters through blood vessels to access and treat the aneurysm, which can be less traumatic for patients and result in better outcomes.

The global intracranial aneurysm market showcases intriguing regional insights, with two regions standing out prominently - North America as the dominating region and Asia-Pacific as the fastest-growing region. North America, with its well-established healthcare infrastructure and a high prevalence of risk factors like hypertension and smoking, holds the lion's share of the market, commanding approximately 40% of the total market revenue. The region boasts cutting-edge medical technologies and a skilled pool of neurosurgeons, making it a key destination for intracranial aneurysm treatments. For instance, renowned medical centers like the Mayo Clinic and Cleveland Clinic in the United States are at the forefront of offering comprehensive and advanced care for patients with intracranial aneurysms. These centers continuously strive to improve patient outcomes through innovative treatments and research, solidifying North America's dominant position in the market.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Intracranial Aneurysm Market Size, Share, Growth Analysis, By Type(Surgical clipping, endovascular coiling, and flow diverters), By End-use(Hospitals, clinics, and research laboratories), By Region - Industry Forecast 2024-2031

Intracranial Aneurysm Market Competitive Landscape

Intracranial Aneurysm Market Report Snapshots

Want to customize this report?

FAQs

Request Free Customization

Feedback From Our Clients

$5,300

Intracranial Aneurysm Market Size, Share, Growth Analysis, By Type(Surgical clipping, endovascular coiling, and flow diverters), By End-use(Hospitals, clinics, and research laboratories), By Region - Industry Forecast 2024-2031

Intracranial Aneurysm Market Competitive Landscape

Intracranial Aneurysm Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Intracranial Aneurysm Market?

Who are the key vendors in the Intracranial Aneurysm Market?

What is the key driver of Intracranial Aneurysm Market?

What is the key market trend for Intracranial Aneurysm Market?

Which region accounted for the largest share in Intracranial Aneurysm Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300